ASGR1-TLR8, AN ASGR1-DIRECTED TLR8 IMMUNOTAC(TM) THERAPEUTIC, IS A POTENT MYELOID CELL AGONIST WITH LIVER-LOCALIZED ACTIVITY FOR THE TREATMENT OF CHRONIC HBV-MedSci.cn

ASGR1-TLR8, AN ASGR1-DIRECTED TLR8 IMMUNOTAC(TM) THERAPEUTIC, IS A POTENT MYELOID CELL AGONIST WITH LIVER-LOCALIZED ACTIVITY FOR THE TREATMENT OF CHRONIC HBV

Baum, P; Odegard, V

HEPATOLOGY, 2020; 72 (): 503A

科室
- - 订阅+
  - 更多科室
工具
服务